Pathways - manually collected, often from reviews:
OpenBEL Selventa BEL large corpus:
CDKN2A
→
AR
(decreases)
Evidence: When cells were treated with AR agonist R1881 (Synthetic androgen) down regulation of p16 INK4a was observed. Protein as well as mRNA levels of p16 INK4a were decreased significantly.